• 26 Mar, 2026

Medical News

JB Pharma Hit with ₹80.81 Lakh GST Penalty

JB Pharma Hit with ₹80.81 Lakh GST Penalty

JB Pharma has been hit with a ₹80.81 lakh GST penalty, raising questions about tax compliance in the pharma industry. What led to this action, and should investors be concerned? Here’s a complete breakdown of the case and its implications.

Indian Army Partners with Bhagwan Mahaveer Cancer Hospital: A Landmark Step for Veterans Cancer Care

In a significant move for veteran welfare, the Indian Army has partnered with Bhagwan Mahaveer Cancer Hospital & Research Centre (BMCHRC) Jaipur to provide specialized cancer care to ex-servicemen and their families. This collaboration highlights the growing role of public-private partnerships in ensuring timely, accessible and high-quality healthcare for those who served the nation.

Read More

Dr. Reddy’s Laboratories Receives GST Demand Orders Worth ₹2.20 Crore

Dr. Reddy’s Laboratories one of India’s leading pharmaceutical companies headquartered in Hyderabad, recently made headlines after disclosing GST demand orders totalling approximately ₹2.20 crore for the financial years FY20–22. Reported widely in March 2026, this development highlights the ongoing challenges companies face under India’s complex GST regime even those with strong compliance system.

Read More